Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J5EZ
|
|||
Former ID |
DNC009089
|
|||
Drug Name |
AM-2S
|
|||
Synonyms |
AM-2S; CHEMBL470194; SCHEMBL13208678; BDBM50278743
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H17NO3S
|
|||
Canonical SMILES |
CC1=CC(=S)C(=C(O1)C(=O)NCC2=CC=C(C=C2)C3=CC=CC=C3)O
|
|||
InChI |
1S/C20H17NO3S/c1-13-11-17(25)18(22)19(24-13)20(23)21-12-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-11,22H,12H2,1H3,(H,21,23)
|
|||
InChIKey |
ZOMMNLRHGAAUNM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Matrix metalloproteinase-3 (MMP-3) | Target Info | Inhibitor | [1] |
KEGG Pathway | TNF signaling pathway | |||
Transcriptional misregulation in cancer | ||||
Rheumatoid arthritis | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
IL4 Signaling Pathway | ||||
Panther Pathway | Plasminogen activating cascade | |||
CCKR signaling map ST | ||||
Pathway Interaction Database | Posttranslational regulation of adherens junction stability and dissassembly | |||
p75(NTR)-mediated signaling | ||||
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
Reactome | Collagen degradation | |||
Degradation of the extracellular matrix | ||||
Activation of Matrix Metalloproteinases | ||||
Assembly of collagen fibrils and other multimeric structures | ||||
EGFR Transactivation by Gastrin | ||||
WikiPathways | Activation of Matrix Metalloproteinases | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Oncostatin M Signaling Pathway | ||||
Matrix Metalloproteinases |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1970-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.